Global Multiplexed Diagnostics Market (2021 to 2029) - Featuring Agilent Technologies, BioMerieux and Hologic Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Multiplexed Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.

Multiplexed diagnostics can detect multiple analytes in a sample through a single run. Multiplexed assays are used in the detection of cancers, infectious diseases and functional biomolecules such as (DNA and mRNA). Multiplexed assays aid in disease diagnosis, molecular diagnosis, and drug development. Multiplexed diagnostics is capable to detect analytes in the limited sample and in short span of time by analyzing hundreds of data points simultaneously. Global multiplexed diagnostics market comprise of reagent and consumables, and analyzers. This report includes a comprehensive market analysis of the global multiplexed diagnostics market for the period 2019 - 2029. Key insights discussed in this report will provide market stakeholders complete understanding of the market and aids in market initiatives including product launch and investment areas.

The global multiplexed diagnostics market is categorized in terms of product type, technology, application, and geographical distribution. Based on product type, global multiplexed diagnostics market is segmented into reagents & consumables, and analyzers. Based on technology, global multiplexed diagnostics market is segmented into low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high density multiplexed assays, and next-generation sequencing assays. The application areas of multiplexed diagnostics are disease diagnostics, molecular diagnostics, and drug development. Each aforementioned segment is analyzed for the year 2019 - 2029 and CAGRs are calculated for the forecast period.

Market analysis of geographical categorization is presented for the period 2019 - 2029 with CAGRs for the forecast period. Also, the analysis is further sub-segmented in terms of product type, technology, application, and countries.

Along with quantitative analysis of the global multiplexed diagnostics market, this study also provides qualitative evaluation factors of the market. The report provides key insights related to market drivers and restraints, new product launches and approval and competitive strategies of the leading players. Major players are profiled in the report based on financial performance, product portfolio, and development strategies.

Companies Mentioned

• Agilent Technologies
• BioMerieux SA
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Illumina Inc.
• Luminex Corporation
• Siemens Healthineers
• Abbott Laboratories
• Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Multiplexed Diagnostics Market: Market Dynamics and Outlook

3.1. Market Definition and Overview

3.2. Drivers

3.3. Challenges

3.4. Opportunities

3.5. Attractive Investment Proposition, by Geography

3.6. Value Chain Analysis

3.7. Porter's Five Forces Model

3.8. Competitive Landscape

3.8.1. Competitive Landscape, by Key Players, 2020

Chapter 4. Multiplexed Diagnostics Market, by Product Type, 2019 - 2029 (US$ Mn)

4.1. Overview

4.1.1. Attractive Investment Proposition, by Product Type, 2020

4.2. Reagents & Consumables

4.3. Analyzers

Chapter 5. Multiplexed Diagnostics Market, by Technology, 2019 - 2029 (US$ Mn)

5.1. Overview

5.1.1. Comparative Analysis: Global Multiplexed Diagnosis Market, by Technology, 2020 Vs 2025 (Value %)

5.2. Very High Density Multiplexed Assays

5.3. High Density Multiplexed Assays

5.4. Medium Density Multiplexed Assays

5.5. Low Density Multiplexed Assays

5.6. Next Generation Sequencing Assays

Chapter 6. Multiplexed Diagnostics Market, by Application, 2019 - 2029 (US$ Mn)

6.1. Overview

6.2. Disease Diagnostics

6.3. Molecular Diagnostics

6.4. Drug Development

Chapter 7. Multiplexed Diagnostics Market, by Geography, 2019 - 2029 (US$ Mn)

7.1. Overview

7.2. North America Multiplexed Diagnostics Market Analysis, 2019 - 2029 (US$ Mn)

7.3. Europe Multiplexed Diagnostics Market Analysis, 2019 - 2029 (US$ Mn)

7.4. Asia Pacific Multiplexed Diagnostics Market Analysis, 2019 - 2029 (US$ Mn)

7.5. Latin America Multiplexed Diagnostics Market Analysis , 2019 - 2029 (US$ Mn)

7.6. Middle East & Africa (MEA) Multiplexed Diagnostics Market Analysis, 2019 - 2029 (US$ Mn)

7.6.1. MEA Multiplexed Diagnostics Market, by Product Type, 2019 - 2029 (US$ Mn)

7.6.2. MEA Multiplexed Diagnostics Market, by Technology, 2019 - 2029 (US$ Mn)

7.6.3. MEA Multiplexed Diagnostics Market, by Application, 2019 - 2029 (US$ Mn)

7.6.4. MEA Multiplexed Diagnostics Market, by Region, 2019 - 2029 (US$ Mn)

7.6.4.1. GCC

7.6.4.2. Rest of MEA

Chapter 8. Company Profiles

8.1. Abbott Laboratories

8.1.1. Business Description

8.1.2. Financial Information (Subject to data availability)

8.1.3. Application Portfolio

8.1.4. Key Developments

8.2. Agilent Technologies

8.3. Baxter International, Inc.

8.4. BioMerieux SA

8.5. Bio-Rad Laboratories

8.6. F. Hoffmann-La Roche Ltd.

8.7. Hologic, Inc.

8.8. Illumina, Inc.

8.9. Luminex Corporation

8.10. Siemens Healthineers

8.11. Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ijdbkg